Caplin Steriles Limited received final USFDA approval for its generic Foscarnet Sodium Injection ANDA.
The approved drug is a generic equivalent to Clinigen's Foscavir with US sales of ~$15M for 12 months ending March 2026.
This marks the subsidiary's 55th ANDA approval as it develops a pipeline of 55+ injectable and ophthalmic products.